General Biotechnology

We are in the midst of dramatic changes in the way life sciences companies are funded. The model of funding a company with venture capital leading to an IPO is now the exception rather than the rule for life sciences companies. Venture investors are no…

Molecular diagnostic (MDx) tests are now commonplace in virtually every hospital and pathology laboratory, however many questions have arisen, such as “What do diagnostic laboratories require from the MDx revolution in order to better improve patient…

In 2010 healthcare represented 17.9% of GDP; its cost is growing significantly faster (~5%) than economic growth (~ 2%).  This growth presents a challenge to all payers, whether they are governments, employers, or individuals.  Within healthcare, one…

This article addresses the strategic application of systemic oral transmucosal* (i.e., sublingual and buccal) drug delivery. Circumvention of first-pass hepatic metabolism in the gut, rapid onset of action, easy access via the oral cavity, easy adminis…

Full details at the Journal of Commercial Biotechnology

The ProImmune Company's Immune Formulation 200® Dietary Supplement, a novel Glutathione precursor which replenishes bodily Glutathione, also activates Nrf2. Nrf2 mobilizes approximately 250…(PRWeb June 28, 2012)Read the full story at http…

Garrett will discuss the shortfalls and inadequacies of our current biosurveillance systems and procedures at the upcoming event scheduled for August 27-28 on Capitol Hill(PRWeb June 28, 2012)Read the full story at http://www.prweb.com/releases/2012…

The July 2012 issue of the Journal of Commercial Biotechnology is now available. Contents include Original Articles, From the Boardroom, From the Classroom, Legal and Regulatory Update, and Conference Report